UK publishes radiation protection research programme
This article was originally published in Clinica
The UK's Department of Health has published a report detailing the current Radiation Protection Research programme, which reflects a strategy review completed in 2006. The programme covers the priorities for research into the health effects of exposure to ionising radiation and electromagnetic fields, with a view to steering official radiation protection policy. The document sets out the strategy and the priorities raised by the 2006 programme, and provides details of the projects, including duration, costs and the research teams involved. The themes of the 16 projects include: thermal hazard in neonatal ultrasound; long-term sequelae of CT radiation in childhood; and "characterisation of chromosome damage induced in vitro by alpha irradiation and identification of potential markers of in vivo exposure".
You may also be interested in...
The entry of India’s state-owned Indian Immunologicals and partner Griffith University in the COVID-19 vaccine race could potentially disrupt pricing dynamics. The alliance is developing a live-attenuated, single dose vaccine, which it hopes will be ready for launch in 18-24 months.
Shortly after wrapping up a Phase III trial for its proposed generic Advair Diskus product in the US, Cipla has won FDA approval for the first generic Proventil HFA product, as it continues to build up steam in the US respiratory market.
The UK's MHRA is looking for manufacturers to submit COVID-19 self-tests that meet minimum and desired criteria for evaluation, after finding its recently purchased 3.5m self-tests failed to meet these standards. Criteria include no requirement for testing knowledge or training or assistance from a healthcare professional in administering or interpreting the results of the test, as well as a 95% accuracy level.